Davids MS, Ambrose J, de Nigris E, Prescott J, Leng S, Yang J, Zettler CM, Fernandes LL, Wang C-K, Barr PM. Real-world treatment patterns and outcomes in patients with chronic lymphocytic leukemia previously exposed to both covalent Bruton’s tyrosine kinase inhibitor and B-cell lymphoma 2 inhibitor therapy. Haematologica; https://doi.org/10.3324/haematol.2026.300690 [Early view].